The strong immunostaining of BRAF and PI3KR1 indicated that the primary antibodies used for immunohistochemistry detect not only wildtype but also mutated forms of these proteins and that both proteins were expressed at high levels in this glioblastoma case. Here, BRAF is linked to glioblastoma.